Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BIIB105 for ALS
Recruiting0 awardsPhase 1 & 2
La Jolla, California
This trial is testing BIIB105, a new drug for adults with ALS. The drug aims to lower a protein that may worsen ALS, and it is given through an injection into the spinal fluid.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service